Natural enzyme provides potential new approach for treating graft-vs-host disease
Tuesday, January 17, 2012 - 11:04
in Health & Medicine
A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants.